You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Details for Patent: 9,289,382


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,289,382
Title:Vaginal inserted estradiol pharmaceutical compositions and methods
Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
Inventor(s): Bernick; Brian A. (Boca Raton, FL), Amadio; Julia M. (Boca Raton, FL)
Assignee: TherapeuticsMD, Inc. (Boca Raton, FL)
Application Number:14/624,051
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,289,382
Patent Claim Types:
see list of patent claims
Compound; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,289,382

Introduction

United States Patent 9,289,382, titled "Vaginal inserted estradiol pharmaceutical compositions and methods," is a patent that covers specific pharmaceutical compositions and methods related to vaginal estradiol delivery. Here, we will delve into the details of the patent's scope, claims, and the broader patent landscape in which it resides.

Patent Overview

The patent, filed as US14/624,051 and granted as US9289382B2, pertains to pharmaceutical compositions comprising solubilized estradiol designed for vaginal insertion. This patent is significant in the field of women's health, particularly for treating conditions related to estrogen deficiency.

Claims Analysis

Independent and Dependent Claims

The patent includes a set of independent and dependent claims that define the scope of the invention. Independent claims are standalone and do not rely on other claims, while dependent claims build upon the independent claims to provide additional specificity.

  • Independent Claims: These claims define the core aspects of the invention, such as the composition of the pharmaceutical, the method of preparation, and the method of use. For example, an independent claim might specify the formulation of the estradiol composition and its delivery mechanism.
  • Dependent Claims: These claims further detail the invention by adding specific limitations or features to the independent claims. For instance, a dependent claim might specify the concentration of estradiol, the type of solubilizing agent used, or the shape and size of the vaginal insert.

Claim Scope and Breadth

The scope of the claims is crucial in determining the patent's protection and its impact on the market. Narrower claims, as discussed in the SSRN paper, are often associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

  • Claim Length and Count: The length and number of independent claims can be metrics for measuring patent scope. Generally, shorter and fewer claims indicate a more focused and narrower scope, which can be beneficial in terms of clarity and enforceability[3].

Patent Scope and Quality

The quality of a patent is often debated in terms of its scope, clarity, and validity. Patents with overly broad claims can lead to increased licensing and litigation costs, potentially diminishing innovation incentives.

  • Clarity and Validity: The claims in US9289382B2 must be clear and specific to avoid ambiguity and potential invalidation. Clear claims help in defining the boundaries of the invention, making it easier for others to understand what is protected and what is not.
  • Breadth of Protection: The patent's scope should be balanced to ensure it does not overly restrict future innovations while still protecting the inventor's rights. The detailed technology areas and classifications, such as those used by the World Intellectual Property Organization (WIPO), help in categorizing and analyzing the patent's focus[1].

Industry and Market Impact

The patent landscape in the pharmaceutical sector is highly competitive and regulated.

  • R&D Expenditures: The development of such pharmaceutical compositions often involves significant research and development (R&D) expenditures. For instance, high R&D industries like the pharmaceutical sector tend to have high rates of patenting to protect their investments[1].
  • Regulatory Compliance: Patents in the pharmaceutical field must comply with stringent regulatory requirements. The approval process for new drugs and formulations is rigorous, and patents must align with these regulations to ensure market viability.

Legal and Litigation Aspects

Patents can be subject to legal challenges and litigation, which can impact their validity and enforceability.

  • Patent Infringement: Companies must ensure that their products do not infringe on existing patents. Litigation cases, such as the one involving Mobile Acuity and Blippar, highlight the importance of careful claim drafting and the potential for disputes over patent validity and infringement[2].
  • Small Claims Patent Court: There have been discussions and studies on the feasibility of a small claims patent court to handle smaller-scale patent disputes more efficiently and cost-effectively. This could potentially affect how future patent disputes related to pharmaceutical compositions are handled[5].

Technological Classification

The patent is classified under specific technological fields, which helps in understanding its place within the broader patent landscape.

  • WIPO Classification: The patent would be classified under relevant International Patent Classification (IPC) technical fields, such as those related to pharmaceuticals and medical devices. This classification system aids in aggregating data and analyzing trends in patenting focus over time[1].

Examples and Statistics

  • Patent Activity: The USPTO granted 309,000 utility patents in 2018, with businesses receiving the majority (85%) of these patents. This trend reflects the increased importance of intellectual property protection, especially in high R&D industries like pharmaceuticals[1].
  • Industry Focus: The computer and electronics manufacturing industry, while not directly related to pharmaceuticals, shows high levels of patenting activity. This indicates the broader trend of increased patenting in high-tech and R&D-intensive sectors[1].

Expert Insights

Industry experts and legal practitioners emphasize the importance of clear and specific claims, as well as the need for a balanced approach to patent scope.

  • Balanced Scope: Experts like those involved in the ACUS study on small claims patent courts stress the need for patents that are neither too broad nor too narrow, ensuring they protect innovation without stifling future developments[5].

Key Takeaways

  • Clear Claims: The patent's claims must be clear and specific to avoid ambiguity and potential invalidation.
  • Balanced Scope: The scope of the patent should be balanced to protect the inventor's rights without overly restricting future innovations.
  • Regulatory Compliance: Patents must comply with regulatory requirements, especially in highly regulated sectors like pharmaceuticals.
  • Legal Considerations: Careful claim drafting and awareness of potential litigation are crucial.
  • Technological Classification: Understanding the technological classification helps in analyzing trends and the patent's place within the broader landscape.

FAQs

Q: What is the main focus of United States Patent 9,289,382? A: The main focus is on pharmaceutical compositions comprising solubilized estradiol for vaginal insertion.

Q: How are the claims in this patent structured? A: The patent includes independent and dependent claims, with independent claims defining the core aspects and dependent claims providing additional specificity.

Q: Why is the scope of the claims important? A: The scope of the claims determines the patent's protection and market impact, and overly broad claims can lead to increased litigation costs.

Q: How does this patent fit into the broader patent landscape? A: It is classified under relevant IPC technical fields and reflects the trend of increased patenting in high R&D industries.

Q: What are the potential legal challenges for this patent? A: The patent could face challenges related to validity and infringement, similar to other patents in highly competitive sectors.

Cited Sources

  1. Invention: U.S. and Comparative Global Trends - National Science Foundation.
  2. MOBILE ACUITY LTD. v. BLIPPAR LTD. - United States Court of Appeals for the Federal Circuit.
  3. Patent Claims and Patent Scope - SSRN.
  4. Vaginal inserted estradiol pharmaceutical compositions and methods - Google Patents.
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 9,289,382

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Mayne Pharma IMVEXXY estradiol INSERT;VAGINAL 208564-001 May 29, 2018 RX Yes No 9,289,382 ⤷  Try for Free Y ⤷  Try for Free
Mayne Pharma IMVEXXY estradiol INSERT;VAGINAL 208564-002 May 29, 2018 RX Yes Yes 9,289,382 ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 2 of 2 entries

International Family Members for US Patent 9,289,382

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 2782584 ⤷  Try for Free 301153 Netherlands ⤷  Try for Free
European Patent Office 2782584 ⤷  Try for Free 2021C/558 Belgium ⤷  Try for Free
European Patent Office 2782584 ⤷  Try for Free 122021000080 Germany ⤷  Try for Free
European Patent Office 2782584 ⤷  Try for Free LUC00245 Luxembourg ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.